Oxford begins first human trial of Bundibugyo Ebola vaccine
The University of Oxford has launched the first human clinical trial for a vaccine targeting the Bundibugyo ebolavirus.
🌍 Cross-language spread
This story first appeared in 🇧🇷 Portuguese coverage — 10.1 hours before headlinez.news detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Oxford Vaccine Group has initiated testing for a vaccine candidate developed to combat the Bundibugyo strain of the Ebola virus. This development occurs eight weeks after the onset of the current health emergency.
Reporting from Reuters, the BBC, Sky News, and CEPI highlights the involvement of the University of Oxford and the financial support provided by CEPI. Coverage notes that this marks the first human trial for this specific virus strain.
Future updates will focus on the progression of the trial and data concerning the vaccine's performance. Coverage does not yet specify the anticipated duration of the study or future rollout timelines.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 27m ago.
Quick answers
What is being tested?
A vaccine candidate for the Bundibugyo ebolavirus.
Who is leading the trial?
The Oxford Vaccine Group at the University of Oxford.
Is there outside support?
Yes, the trial is backed by CEPI.
Coverage (6)
- The Ugandan city where the race for a new Ebola vaccine will be won or lost The Telegraph · 14h ago
- Oxford's Bundibugyo ebolavirus response University of Oxford · 14h ago
- Human trials of new Ebola vaccine set to begin in UK Sky News · 14h ago
- CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group CEPI · 14h ago
- UK starts first vaccine trial, eight weeks into Ebola emergency BBC · 14h ago
- Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters · 14h ago
Topics
Related trends
U.S. Citizen Tests Positive for Ebola in Democratic Republic of Congo
A U.S. citizen working in the Democratic Republic of Congo has been diagnosed with Ebola and transferred to a hospital in Germany.
Genomic epidemiology of the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo
Genomic data and logistics challenges define the evolving response to the Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo.
New Congo province has suspected Ebola case as deaths hit 600, report says
Ebola outbreak in Congo escalates as death toll nears 600 and strikes cripple response efforts
Ebola outbreak in Congo still spreading, WHO says
Ebola’s spread in Congo outpaces containment as new cases emerge with no clear source
Ebola deaths in Congo top 500 as health workers threaten to strike
The Ebola outbreak in the Democratic Republic of Congo reaches 600 deaths as labor disputes among health workers intensify.
Ebola outbreak containment hampered by USAID closure, experts say
Concerns grow over Ebola response capabilities following reports that USAID closures are hindering containment efforts.